Literature DB >> 19426610

Carbon monoxide: vascular therapeutic for the future.

Edith Tzeng1.   

Abstract

In the past decade, carbon monoxide has lost its reputation as a toxic gas and has gained a following of scientists who now appreciate its potential therapeutic utility as an anti-inflammatory and cytoprotective agent. Its vasoprotective properties have also gained a tremendous amount of attention, especially its ability to inhibit intimal hyperplasia. This review will provide a historical perspective of carbon monoxide biology and summarize its function in disease modulation with a special focus on its potential role as a vascular therapeutic.

Entities:  

Mesh:

Substances:

Year:  2009        PMID: 19426610     DOI: 10.2310/6670.2008.00090

Source DB:  PubMed          Journal:  Vascular        ISSN: 1708-5381            Impact factor:   1.285


  3 in total

1.  Delayed inhaled carbon monoxide mediates the regression of established neointimal lesions.

Authors:  Michael Madigan; Fateh Entabi; Brian Zuckerbraun; Patricia Loughran; Edith Tzeng
Journal:  J Vasc Surg       Date:  2014-01-11       Impact factor: 4.268

2.  Impairment of nitric oxide synthase but not heme oxygenase accounts for baroreflex dysfunction caused by chronic nicotine in female rats.

Authors:  Mohamed A Fouda; Hanan M El-Gowelli; Sahar M El-Gowilly; Laila Rashed; Mahmoud M El-Mas
Journal:  PLoS One       Date:  2014-05-28       Impact factor: 3.240

3.  Carbon monoxide releasing molecule‑2 (CORM‑2)‑liberated CO ameliorates acute pancreatitis.

Authors:  Yishu Liu; Xu Wang; Xiaohan Xu; Weiting Qin; Bingwei Sun
Journal:  Mol Med Rep       Date:  2019-04-19       Impact factor: 2.952

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.